| Issue Date | Title | Author(s) |
| Oct-2019 | Antiproliferative activity of (R)-4 '-methylklavuzon on hepatocellular carcinoma cells and EpCAM(+)/CD133(+) cancer stem cells via SIRT1 and Exportin-1 (CRM1) inhibition | Delman, Murat; Avcı, Sanem Tercan; Akçok, İsmail; Kanbur, Tuğçe ; Erdal, Esra; Çağır, Ali |
| 2023 | Comparative membrane lipidomics of hepatocellular carcinoma cells reveals diacylglycerol and ceramide as key regulators of Wnt/β-catenin signaling and tumor growth | Azbazdar, Yağmur; Demirci, Yeliz; Heger, Guillaume; İpekgil, Doğaç; Karabiçici, Mustafa; Özhan, Güneş |
| 2017 | CRM1 inhibitory and antiproliferative activities of novel 4'-alkyl substituted klavuzon derivatives | Kanbur, Tuğçe ; Kara, Murat; Kutluer, Meltem; Şen, Ayhan; Delman, Murat; Alkan, Aylin; Otaş, Hasan Ozan; Akçok, İsmail; Çağır, Ali |
| Dec-2017 | The investigation of anticancer properties of (R)-4'-methylklavuzon in liver cancer cells and liver cancer stem cells | Delman, Murat |
| 2020 | Novel 2 '-alkoxymethyl substituted klavuzon derivatives as inhibitors of Topo I and CRM1 | Çetinkaya, Hakkı; Yıldız, Mehmet Salih; Kutluer, Meltem; Alkan, Aylin; Otaş, Hasan Ozan; Çağır, Ali |
| Jan-2017 | Pre-clinical trial treatment of hepatocellular carcinoma on cirrhosis in a rat model | Zeybek Kuyucu, Ayça |
| 2023 | Sorafenib loaded ZIF-8 metal-organic frameworks as a multifunctional nano-carrier offers effective hepatocellular carcinoma therapy | Mete, Derya ; Yemeztaşlıca Yetişkin, Egehan ; Şanlı Mohamed, Gülşah |
